Accuray Incorporated (0H8I.L)
USD 1.55
(2.05%)
USD 1.55
(2.05%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 143.12 Million USD | -7.04% |
| 2022 | 153.96 Million USD | -3.75% |
| 2021 | 159.95 Million USD | 0.28% |
| 2020 | 159.5 Million USD | 6.54% |
| 2019 | 149.72 Million USD | -7.95% |
| 2018 | 162.65 Million USD | 0.59% |
| 2017 | 161.69 Million USD | 14.4% |
| 2016 | 141.34 Million USD | -10.95% |
| 2015 | 158.71 Million USD | 9.15% |
| 2014 | 145.4 Million USD | 1.82% |
| 2013 | 142.8 Million USD | 46.25% |
| 2012 | 97.64 Million USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 FY | 142.92 Million USD | -7.17% |
| 2023 Q2 | 35.9 Million USD | -9.09% |
| 2023 Q3 | 29.07 Million USD | -19.02% |
| 2023 Q4 | 38.45 Million USD | 32.26% |
| 2023 Q1 | 39.49 Million USD | 4.82% |
| 2022 Q4 | 37.67 Million USD | -2.69% |
| 2022 FY | 153.96 Million USD | -3.75% |
| 2022 Q3 | 38.71 Million USD | -9.89% |
| 2022 Q2 | 42.96 Million USD | 24.19% |
| 2022 Q1 | 34.59 Million USD | -19.58% |
| 2021 Q1 | 39.52 Million USD | -9.62% |
| 2021 Q2 | 42.62 Million USD | 7.85% |
| 2021 Q3 | 34.78 Million USD | -18.4% |
| 2021 Q4 | 43.02 Million USD | 23.68% |
| 2021 FY | 159.95 Million USD | 0.28% |
| 2020 Q3 | 39.54 Million USD | -3.16% |
| 2020 Q1 | 35.4 Million USD | -10.92% |
| 2020 Q4 | 43.73 Million USD | 10.59% |
| 2020 Q2 | 40.83 Million USD | 15.33% |
| 2020 FY | 159.5 Million USD | 6.54% |
| 2019 Q4 | 39.74 Million USD | 1.56% |
| 2019 Q1 | 32.94 Million USD | -28.27% |
| 2019 Q2 | 37.9 Million USD | 15.05% |
| 2019 FY | 149.72 Million USD | -7.95% |
| 2019 Q3 | 39.13 Million USD | 3.25% |
| 2018 Q4 | 45.92 Million USD | 13.49% |
| 2018 Q3 | 40.46 Million USD | 5.44% |
| 2018 Q2 | 38.38 Million USD | 1.32% |
| 2018 Q1 | 37.87 Million USD | -21.06% |
| 2018 FY | 162.65 Million USD | 0.59% |
| 2017 Q1 | 38.1 Million USD | -11.76% |
| 2017 FY | 161.69 Million USD | 14.4% |
| 2017 Q4 | 47.98 Million USD | 32.38% |
| 2017 Q3 | 36.24 Million USD | -7.89% |
| 2017 Q2 | 39.35 Million USD | 3.28% |
| 2016 Q4 | 43.18 Million USD | 21.91% |
| 2016 Q3 | 35.42 Million USD | 12.87% |
| 2016 Q2 | 31.38 Million USD | 0.14% |
| 2016 Q1 | 31.34 Million USD | -15.97% |
| 2016 FY | 141.34 Million USD | -10.95% |
| 2015 Q4 | 37.3 Million USD | -17.01% |
| 2015 Q1 | 33.89 Million USD | -16.2% |
| 2015 Q3 | 44.94 Million USD | 5.57% |
| 2015 Q2 | 42.57 Million USD | 25.59% |
| 2015 FY | 158.71 Million USD | 9.15% |
| 2014 FY | 145.4 Million USD | 1.82% |
| 2014 Q4 | 40.45 Million USD | 4.64% |
| 2014 Q1 | 27.8 Million USD | -27.69% |
| 2014 Q3 | 38.66 Million USD | 0.44% |
| 2014 Q2 | 38.48 Million USD | 38.44% |
| 2013 Q1 | 26.47 Million USD | -2.96% |
| 2013 Q3 | 39.7 Million USD | 4.02% |
| 2013 Q4 | 38.44 Million USD | -3.17% |
| 2013 FY | 142.8 Million USD | 46.25% |
| 2013 Q2 | 38.17 Million USD | 44.16% |
| 2012 Q4 | 27.28 Million USD | 36.06% |
| 2012 Q3 | 20.05 Million USD | -24.69% |
| 2012 Q2 | 26.62 Million USD | 0.0% |
| 2012 FY | 97.64 Million USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Phreesia, Inc. | 201.74 Million USD | 29.058% |
| Align Technology, Inc. | 2.72 Billion USD | 94.739% |
| Elevance Health Inc. | 47.01 Billion USD | 99.696% |
| AxoGen, Inc. | 127.87 Million USD | -11.923% |
| Boston Scientific Corporation | 9.84 Billion USD | 98.547% |
| CVS Health Corporation | 54.43 Billion USD | 99.737% |
| Cardinal Health, Inc. | 7.41 Billion USD | 98.07% |
| Centene Corporation | 153.99 Billion USD | 99.907% |
| DaVita Inc. | 3.82 Billion USD | 96.254% |
| HCA Healthcare, Inc. | 55.06 Billion USD | 99.74% |
| Hologic, Inc. | 2.23 Billion USD | 93.604% |
| Humana Inc. | 106.44 Billion USD | 99.866% |
| IDEXX Laboratories, Inc. | 2.18 Billion USD | 93.465% |
| Laboratory Corporation of America Holdings | 3.36 Billion USD | 95.747% |
| Masimo Corporation | 1 Billion USD | 85.738% |
| McKesson Corporation | 12.58 Billion USD | 98.863% |
| Patterson Companies, Inc. | 1.38 Billion USD | 89.631% |
| Quest Diagnostics Incorporated | 2.96 Billion USD | 95.166% |
| ResMed Inc. | 2.6 Billion USD | 94.514% |
| Henry Schein, Inc. | 3.65 Billion USD | 96.08% |
| Teladoc Health, Inc. | 1.84 Billion USD | 92.232% |
| Universal Health Services, Inc. | 1.17 Billion USD | 87.823% |
| Veeva Systems Inc. | 1.68 Billion USD | 91.513% |
| Baxter International Inc. | 4.97 Billion USD | 97.123% |
| Becton, Dickinson and Company | 8.82 Billion USD | 98.378% |
| Intuitive Surgical, Inc. | 4.72 Billion USD | 96.974% |
| Danaher Corporation | 14.12 Billion USD | 98.987% |
| Stryker Corporation | 13.05 Billion USD | 98.904% |
| Medtronic plc | 21.27 Billion USD | 99.327% |